FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
52.1x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndTotal non-current liabilities (Million JPY)YoY (%)
Mar 31, 2025395-68.69%
Mar 31, 20241,260-33.17%
Mar 31, 20231,886-32.26%
Mar 31, 20222,784-14.38%
Mar 31, 20213,252+180.06%
Mar 31, 20201,161-71.49%
Mar 31, 20194,073-33.02%
Mar 31, 20186,081-18.30%
Mar 31, 20177,443+56.43%
Mar 31, 20164,758+388.97%
Mar 31, 2015973
AI Chat